Canada Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
122 Pages - SKU: BMI5325544
Countries covered: Canada

Canada Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: Canada will continue to attract pharmaceutical companies to launch innovative medicines dueto the hospitable business environment, improving healthcare coverage and broader drug reimbursementlists. The regulatory authority also encourages pharmaceutical companies to invest in research anddevelopment. However, cost containment policies in the public healthcare sector will continue to putpressure on Canada's medicine prices.

Headline Expenditure Projections

Pharmaceuticals: CAD25.6bn (USD24.9bn) in 2013 to CAD25.9bn (USD22.5bn) in 2014; +0.8% inlocal currency terms and -9.7% in US dollar terms. Forecast unchanged from Q314.



More Prescription Drugs reports by Business Monitor International

Venezuela Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q4 2014BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports frompolitical allies and the potential expansion of free medicine ...
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescriptionnumbers, does not come ...
Switzerland Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q4 2014BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increasedpharmaceutical and healthcare spending. The proportion of ...
Qatar Pharmaceuticals and Healthcare Report Q4 2014 by Business Monitor International
Qatar Pharmaceuticals and Healthcare Report Q4 2014BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental topharmaceutical ...
See all reports like this >>

More Canada Prescription Drugs reports

Pharmaceuticals in Canada by MarketLine
Pharmaceuticals in CanadaIntroductionPharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). ...
Canada Pharmaceutical Industry by Aruvian's R'search
Canada Pharmaceutical IndustryThe Canadian pharmaceutical market is the eighth largest in the world, accounting for about two percent of the world market by sales. Canada ...
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022SummaryDuring the forecast period from 2012-2022, the growth of the UC market will be ...
Pharmaceuticals in Canada: ISIC 2423 by Euromonitor International
Pharmaceuticals in Canada: ISIC 2423Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!